First Page | Document Content | |
---|---|---|
![]() Date: 2009-06-10 21:38:09Pharmaceutical sciences Center for Devices and Radiological Health Medical device Premarket approval Regulatory requirement Adverse event Criticism of the Food and Drug Administration Title 21 CFR Part 11 Food and Drug Administration Medicine Health | Add to Reading List |
![]() | United States Government Accountability Office GAO Testimony Before the Subcommittee on OversightDocID: 1rfHg - View Document |
![]() | U.S. Food and Drug Administration A Special Report Pathway to Global Product Safety and QualityDocID: 1qeH2 - View Document |
![]() | HEALTHNET NEWS A newsletter for public librarians and others interested in consumer health information services Volume XXII Number 2DocID: 1p4wR - View Document |
![]() | Rx R&D Myths: The Case Against The Drug Industry’s R&D “Scare Card” Congress Watch July 2001DocID: 12IIT - View Document |
![]() | foSU.V1l:$ofJ (-~:1 -l MEMORANDUMDocID: XIVA - View Document |